Skip to main content
Bureau of AI
Category: Roles & Accountability

Authorized Representative

Also known as:
Simply put

An authorized representative is a person or organization that someone permits to act on their behalf when dealing with an application, appeal, or program. Depending on the context, this can range from a trusted helper who assists an individual with enrollment or benefits to an individual who has the legal authority to make binding commitments for an entity. The specific powers granted vary by the program and the terms of the authorization.

Formal definition

As commonly defined across the sources provided, an authorized representative is a person or organization designated by an applicant, participant, or entity to act on their behalf in specified matters. In benefits and program contexts (for example, MO HealthNet, Temporary Assistance, SNAP, health-insurance marketplace applications, and Medicare enrollment), the role typically involves permission to communicate about an application or appeal, access the principal's information, and assist with enrollment or benefits management. In an entity-certification context, an authorized representative may instead be an individual with legal authority to bind the government entity (for example, a chief executive officer). The scope of authority is not uniform and is determined by the appointing instrument and the governing program's rules. Note: the evidence provided addresses public-benefits and government-certification usages and does not establish an AI governance or model risk management definition; any application to those domains would require separate, sector-specific sourcing.

Why it matters

The term "authorized representative" carries real legal and operational weight because it determines who may lawfully act, communicate, or make commitments on behalf of another party. In public-benefits and program contexts, the designation controls who can see an applicant's information, discuss an application or appeal, and assist with enrollment or ongoing benefits management. Getting this wrong can mean either improperly disclosing a principal's protected information to someone lacking authority, or failing to recognize a validly appointed helper and thereby obstructing an applicant's access to benefits.

The stakes rise further in entity-certification contexts, where an authorized representative may be an individual with legal authority to bind an organization—for example, a chief executive officer signing a certification on behalf of a government entity. Here the designation is not merely about assistance; it establishes accountability and enforceability. Treating a helper with narrow permission as if they had binding authority, or vice versa, introduces both compliance and contractual risk.

Because the scope of authority is not uniform and depends on the appointing instrument and the governing program's rules, professionals should not assume a single definition transfers across programs. The evidence here addresses public-benefits and government-certification usages only; it does not establish an AI governance or model risk management meaning, and any use in those domains would require separate, sector-specific sourcing rather than extension by analogy.

Who it's relevant to

Benefits and program applicants and participants
Individuals applying for or managing benefits (for example, MO HealthNet, Temporary Assistance, SNAP, marketplace coverage, or Medicare) rely on the authorized representative designation to permit a trusted person or organization to communicate about an application or appeal, access their information, and assist with enrollment and ongoing benefits management.
Program administrators and eligibility staff
Staff processing applications and appeals must verify that a person claiming to act on an applicant's behalf holds a valid authorization before disclosing information or accepting instructions, since the permitted actions depend on the appointing instrument and the governing program's rules.
Government and other entities undergoing certification
In entity-certification processes, the authorized representative is typically the individual with legal authority to bind the entity—for example, a chief executive officer—so organizations must ensure the correct person is designated to sign or commit on their behalf.
Legal and compliance professionals
Those advising on program participation or certification should confirm the scope of authority granted, because the powers of an authorized representative are not uniform and range from limited assistance to binding legal commitment depending on context and the terms of the authorization.

Inside AR

Designated legal role
An authorized representative is, in many regulatory frameworks, a natural or legal person designated by a provider or supplier to act on its behalf for specified obligations. The scope of authority is defined by a written mandate rather than being open-ended.
Jurisdictional trigger
The concept commonly arises where an obligated entity is established outside the jurisdiction in which its product or system is placed on the market, creating the need for a locally reachable point of accountability. The precise triggering conditions vary by instrument and jurisdiction.
Written mandate
The relationship is typically constituted by a documented appointment that enumerates which tasks the representative may or must perform, and which obligations remain with the appointing party. Authority not granted in the mandate is generally not assumed.
Contact and cooperation function
A frequent core element is serving as a point of contact for competent authorities and cooperating with them on request, which may include making documentation available. This is an interface function and does not necessarily transfer primary responsibility for the underlying obligations.
Record-keeping and documentation duties
In several frameworks the representative is expected to keep specified documentation available for a defined period and to provide it to authorities. The exact documents and retention periods depend on the applicable instrument.
Boundary of accountability
The role delineates what is delegated versus what remains with the provider or supplier. It is a governance mechanism that assigns a reachable accountable interface; it does not, on its own, measure or control the technical risk of any underlying model.

Common questions

Answers to the questions practitioners most commonly ask about AR.

Is an authorized representative the same as the provider of an AI system?
No. The two roles are commonly distinguished: the provider is the entity that develops an AI system (or has it developed) and places it on the market or puts it into service, while an authorized representative is a separate natural or legal person designated to act on the provider's behalf, typically for compliance and liaison purposes. Conflating the two is a frequent error. The authorized representative does not become the developer of the system by virtue of the designation; rather, it carries out specified tasks under a mandate. The precise allocation of responsibilities between provider and authorized representative depends on the governing framework and the terms of the written mandate, so you should not assume the representative absorbs all provider obligations.
Does appointing an authorized representative transfer the provider's legal liability to that representative?
Not in the way this is often assumed. Designating an authorized representative generally does not extinguish the provider's own obligations, and it should not be treated as a mechanism to shift underlying accountability away from the provider. In many frameworks the representative takes on defined, delegated tasks and may serve as a point of contact for authorities, but the provider typically retains primary responsibility for the system's conformity. The exact division of liability is determined by the applicable law and the mandate, and treating the appointment as a full liability transfer is a common misconception rather than a settled legal outcome.
How should the mandate between a provider and its authorized representative be structured?
As commonly practiced, the relationship is set out in a written mandate that specifies which tasks the representative is authorized to perform, the scope and duration of the authorization, and the conditions under which it may be terminated. Organizations typically ensure the mandate identifies the specific systems covered, the documentation the representative may access or hold, and its role in interacting with authorities. Because the precise required contents can vary by jurisdiction and framework, legal review of the mandate against the applicable requirements is advisable, and this entry does not prescribe clause-level terms.
What records should an organization keep to evidence the authorized representative arrangement?
In practice, organizations maintain the signed mandate, evidence of the representative's identity and contact details, and a defined record of the tasks assigned. It is also common to retain documentation demonstrating that the representative can respond to authority requests and can access or produce relevant technical and compliance documentation. Retention practices should be aligned with the record-keeping expectations of the governing framework; this entry does not specify particular retention periods, as these depend on the applicable rules.
Where does the authorized representative function fit within an organization's governance structure?
The authorized representative role is generally an externally facing compliance and liaison function and should not be confused with internal governance roles such as model owners, validators, or oversight committees. Within a lines-of-defense model, the representative's activities typically support compliance interactions but do not, on their own, constitute independent challenge or validation. Organizations commonly clarify in policy how the representative coordinates with internal accountable owners so that designation of a representative does not create ambiguity about who holds internal oversight responsibility.
When might an organization need to review or update an authorized representative designation?
Common triggers for review include changes to the systems covered by the mandate, changes in the representative's status or capacity to perform its tasks, changes in the provider's own arrangements, and changes in the applicable regulatory requirements. Because the appropriateness of a designation can shift as products or rules evolve, organizations often build periodic review of the mandate into their governance processes. The specific circumstances requiring re-designation depend on the governing framework and are not fixed universally.

Common misconceptions

An authorized representative assumes full legal liability for the product or AI system in place of the provider.
In many frameworks the representative's obligations are limited to those set out in the written mandate and in the applicable law, such as acting as a contact point and holding documentation. Primary substantive responsibility for the system typically remains with the provider or supplier unless a specific instrument states otherwise.
Appointing an authorized representative is a model risk management control that reduces the technical risk of the model.
The authorized representative is an AI governance and accountability mechanism concerned with organizational and jurisdictional oversight. It does not identify, measure, or mitigate model risk such as performance degradation or bias; those are addressed through validation, monitoring, and other risk controls that remain distinct from the representative's role.
The authorized representative requirement is uniform and applies the same way across all regulatory regimes.
The role's existence, scope, and triggering conditions differ by instrument and jurisdiction, and the term can carry sector-specific meaning. Whether a given framework imposes such a requirement, and what it entails, should be confirmed against the specific applicable law rather than assumed to be interchangeable across regimes.

Best practices

Confirm whether an authorized representative is actually required under the specific instrument and jurisdiction that applies to your system, rather than assuming a uniform requirement across regimes.
Define the representative's authority in a written mandate that explicitly enumerates delegated tasks and clearly states which obligations remain with the provider or supplier.
Maintain a documented boundary of accountability so that internal stakeholders understand what the representative does and does not cover, avoiding the assumption that appointment transfers primary responsibility.
Treat the appointment as an AI governance control and keep it distinct from model risk management activities such as validation, monitoring, and performance testing, which must be maintained separately.
Ensure the representative can act as a functional point of contact for competent authorities and can access the documentation it is expected to hold for the required period.
Review and update the mandate when the system, its market placement, or the applicable regulatory treatment changes, using qualified language in internal records where regulatory obligations are still evolving or uncertain.